DJ-1 promotes angiogenesis and osteogenesis by activating FGF receptor-1 signaling

Nature Communications

Volumn 3, Issue , 2012, Pages

  Kim, Jung Min ^a   Shin, Hong In ^b   Cha, Sun Shin ^c   Lee, Chang Sup ^d   Hong, Bok Sil ^e   Lim, Seyoung ^a   Jang, Hyun Jun ^a,e   Kim, Jaeyoon ^e   Yang, Yong Ryoul ^a   Kim, Yun Hee ^f   Yun, Sanguk ^g   Rijal, Girdhari ^b   Lee Kwon, Whaseon ^a   Seo, Jeong Kon ^a   Gho, Yong Song ^e   Ryu, Sung Ho ^e   Hur, Eun Mi ^h   Suh, Pann Ghill ^a  

^a Ulsan National Institute of Science and Technology   (South Korea)

^b Kyungpook National University   (South Korea)

^c Korea Research Institute of Ships and Ocean Engineering   (South Korea)

^d UNIVERSITY OF VIRGINIA   (United States)

^e Pohang University of Science and Technology (POSTECH)   (South Korea)

^f National Cancer Center   (South Korea)

^g YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h Korea Institute of Science and Technology   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

3 [4 METHYL 2 (2 OXO 3 INDOLINYLMETHYLIDENYL) 3 PYRROLYL]PROPIONIC ACID; DJ 1 PROTEIN; FIBROBLAST GROWTH FACTOR RECEPTOR 1;

BLOOD; BONE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC ENGINEERING; GROWTH RATE; MOLECULAR ANALYSIS; SECRETION; SIGNALING;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL; BONE; BONE DEVELOPMENT; BONE REGENERATION; BONE REMODELING; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; CELL STIMULATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FRACTURE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RODENT; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL;

RODENTIA;

EID: 84871775091     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms2313     Document Type: Article

References (54)

1. Liekens, S., De Clercq, E. & Neyts, J. Angiogenesis: regulators and clinical applications. Biochem. Pharmacol. 61, 253-270 (2001).
2. Thompson, J. A. et al. Site-directed neovessel formation in vivo. Science 241, 1349-1352 (1988).
3. Presta, M., Moscatelli, D., Joseph-Silverstein, J. & Rifkin, D. B. Purification from a human hepatoma cell line of a basic fibroblast growth factor-like molecule that stimulates capillary endothelial cell plasminogen activator production, DNA synthesis, and migration. Mol. Cell. Biol. 6, 4060-4066 (1986).
4. Turner, N. & Grose, R. Fibroblast growth factor signalling: from development to cancer. Nat. Rev. Cancer 10, 116-129 (2010).
5. Presta, M. et al. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev. 16, 159-178 (2005).
6. Beenken, A. & Mohammadi, M. The FGF family: biology, pathophysiology and therapy. Nat. Rev. Drug Discov. 8, 235-253 (2009).
7. Cross, M. J. & Claesson-Welsh, L. FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol. Sci. 22, 201-207 (2001).
8. Shing, Y. et al. Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. Science 223, 1296-1299 (1984).
9. Antoine, M. et al. Expression pattern of fibroblast growth factors (FGFs), their receptors and antagonists in primary endothelial cells and vascular smooth muscle cells. Growth Factors 23, 87-95 (2005).
10. Nourse, M. B., Rolle, M. W., Pabon, L. M. & Murry, C. E. Selective control of endothelial cell proliferation with a synthetic dimerizer of FGF receptor-1. Lab. Invest. 87, 828-835 (2007).
11. Seghezzi, G. et al. Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J. Cell Biol. 141, 1659-1673 (1998).
12. Athanasopoulos, A. N. et al. Vascular endothelial growth factor (VEGF)- induced up-regulation of CCN1 in osteoblasts mediates proangiogenic activities in endothelial cells and promotes fracture healing. J. Biol. Chem. 282, 26746-26753 (2007).
13. Carano, R. A. & Filvaroff, E. H. Angiogenesis and bone repair. Drug Discov. Today 8, 980-989 (2003).
14. Gerstenfeld, L. C., Cullinane, D. M., Barnes, G. L., Graves, D. T. & Einhorn, T. A. Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J. Cell Biochem. 88, 873-884 (2003).
15. Wan, C. et al. Activation of the hypoxia-inducible factor-1alpha pathway accelerates bone regeneration. Proc. Natl Acad. Sci. USA 105, 686-691 (2008).
16. Maes, C. et al. Placental growth factor mediates mesenchymal cell development, cartilage turnover, and bone remodeling during fracture repair. J. Clin. Invest. 116, 1230-1242 (2006).
17. Gerber, H. P. & Ferrara, N. Angiogenesis and bone growth. Trends Cardiovasc. Med. 10, 223-228 (2000).
18. Clarkin, C. E., Emery, R. J., Pitsillides, A. A. & Wheeler-Jones, C. P. Evaluation of VEGF-mediated signaling in primary human cells reveals a paracrine action for VEGF in osteoblast-mediated crosstalk to endothelial cells. J. Cell. Physiol. 214, 537-544 (2008).
19. Schmid, G. J., Kobayashi, C., Sandell, L. J. & Ornitz, D. M. Fibroblast growth factor expression during skeletal fracture healing in mice. Dev. Dyn. 238, 766-774 (2009).
20. Grellier, M., Bordenave, L. & Amedee, J. Cell-to-cell communication between osteogenic and endothelial lineages: implications for tissue engineering. Trends Biotechnol. 27, 562-571 (2009).
21. Akeno, N., Robins, J., Zhang, M., Czyzyk-Krzeska, M. F. & Clemens, T. L. Induction of vascular endothelial growth factor by IGF-I in osteoblast-like cells is mediated by the PI3K signaling pathway through the hypoxia-inducible factor-2alpha. Endocrinology 143, 420-425 (2002).
22. Nagakubo, D. et al. DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochem. Biophys. Res. Commun. 231, 509-513 (1997).
23. Bonifati, V. et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299, 256-259 (2003).
24. Lee, S. J. et al. Crystal structures of human DJ-1 and Escherichia coli Hsp31, which share an evolutionarily conserved domain. J. Biol. Chem. 278, 44552-44559 (2003).
25. Zhou, W. & Freed, C. R. DJ-1 up-regulates glutathione synthesis during oxidative stress and inhibits A53T alpha-synuclein toxicity. J. Biol. Chem. 280, 43150-43158 (2005).
26. Canet-Aviles, R. M. et al. The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc. Natl Acad. Sci. USA 101, 9103-9108 (2004).
27. Le Naour, F. et al. Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer. Clin. Cancer Res. 7, 3328-3335 (2001).
28. Pardo, M. et al. The characterization of the invasion phenotype of uveal melanoma tumour cells shows the presence of MUC18 and HMG-1 metastasis markers and leads to the identification of DJ-1 as a potential serum biomarker. Int. J. Cancer 119, 1014-1022 (2006).
29. Klein, R. S. et al. Novel 6-substituted uracil analogs as inhibitors of the angiogenic actions of thymidine phosphorylase. Biochem. Pharmacol. 62, 1257-1263 (2001).
30. Motamed, K. SPARC (osteonectin/BM-40). Int. J. Biochem. Cell Biol. 31, 1363-1366 (1999).
31. Sage, E. H. et al. Cleavage of the matricellular protein SPARC by matrix metalloproteinase 3 produces polypeptides that influence angiogenesis. J. Biol. Chem. 278, 37849-37857 (2003).
32. Amin, M. A. et al. Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinase. Circ. Res. 93, 321-329 (2003).
33. Arnaoutova, I. & Kleinman, H. K. In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract. Nat. Protoc. 5, 628-635 (2010).
34. Klint, P., Kanda, S., Kloog, Y. & Claesson-Welsh, L. Contribution of Src and Ras pathways in FGF-2 induced endothelial cell differentiation. Oncogene 18, 3354-3364 (1999).
35. Huang, Y. C., Simmons, C., Kaigler, D., Rice, K. G. & Mooney, D. J. Bone regeneration in a rat cranial defect with delivery of PEI-condensed plasmid DNA encoding for bone morphogenetic protein-4 (BMP-4). Gene Ther. 12, 418-426 (2005).
36. Peng, H. et al. VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J. Bone. Miner. Res. 20, 2017-2027 (2005).
37. Patel, Z. S. et al. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone 43, 931-940 (2008).
38. Yun, J. I. et al. Effect of systemic parathyroid hormone (1-34) and a betatricalcium phosphate biomaterial on local bone formation in a critical-size rat calvarial defect model. J. Clin. Periodontol. 37, 419-426 (2010).
39. Schipani, E., Maes, C., Carmeliet, G. & Semenza, G. L. Regulation of osteogenesis-angiogenesis coupling by HIFs and VEGF. J. Bone Miner. Res. 24, 1347-1353 (2009).
40. Hankenson, K. D., Dishowitz, M., Gray, C. & Schenker, M. Angiogenesis in bone regeneration. Injury 42, 556-561 (2011).
41. Street, J. et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc. Natl Acad. Sci. USA 99, 9656-9661 (2002).
42. Behr, B., Tang, C., Germann, G., Longaker, M. T. & Quarto, N. Locally applied vascular endothelial growth factor A increases the osteogenic healing capacity of human adipose-derived stem cells by promoting osteogenic and endothelial differentiation. Stem Cells 29, 286-296 (2011).
43. Montero, A. et al. Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J. Clin. Invest. 105, 1085-1093 (2000).
44. Xiao, L. et al. Disruption of the Fgf2 gene activates the adipogenic and suppresses the osteogenic program in mesenchymal marrow stromal stem cells. Bone 47, 360-370 (2010).
45. Kawaguchi, H. et al. A local application of recombinant human fibroblast growth factor 2 for tibial shaft fractures: A randomized, placebo-controlled trial. J. Bone Miner. Res. 25, 2735-2743 (2010).
46. Monfoulet, L. E. et al. Thyroid hormone receptor beta mediates thyroid hormone effects on bone remodeling and bone mass. J. Bone Miner. Res. 26, 2036-2044 (2011).
47. Zhong, N. et al. DJ-1 transcriptionally up-regulates the human tyrosine hydroxylase by inhibiting the sumoylation of pyrimidine tract-binding proteinassociated splicing factor. J. Biol. Chem. 281, 20940-20948 (2006).
48. Tsuboi, Y. et al. DJ-1, a causative gene product of a familial form of Parkinson's disease, is secreted through microdomains. FEBS Lett. 582, 2643-2649 (2008).
49. Lanner, F. & Rossant, J. The role of FGF/Erk signaling in pluripotent cells. Development 137, 3351-3360 (2010).
50. Peng, H. et al. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J. Clin. Invest. 110, 751-759 (2002).
51. Gregory, C. A., Gunn, W. G., Peister, A. & Prockop, D. J. An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal. Biochem. 329, 77-84 (2004).
52. Yoon, C. M. et al. Sphingosine-1-phosphate promotes lymphangiogenesis by stimulating S1P1/Gi/PLC/Ca2+ signaling pathways. Blood 112, 1129-1138 (2008).
53. Kondo, T. et al. Epigenetically controlled fibroblast growth factor receptor 2 signaling imposes on the RAS/BRAF/mitogen-activated protein kinase pathway to modulate thyroid cancer progression. Cancer Res. 67, 5461-5470 (2007).
54. Kim, R. H. et al. Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl- 1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proc. Natl Acad. Sci. USA 102, 5215-5220 (2005).